The formation of the Zn‐proteome involves a complex array of interactions of Zn
2+
with cellular proteins, beginning with transporters that govern the movement of Zn
2+
into and from the cytosol and organelles. Within these compartments, free Zn
2+
concentration is maintained at nanomolar to picomolar levels through extensive buffering by components of the proteome such as metallothionein. Current information favors the buffer as the source of Zn
2+
for the constitution of native Zn‐proteins; but neither equilibrium nor kinetic results demonstrate clearly how trafficking of Zn
2+
to specific sites occurs. The chemical basis of Zn
2+
‐based signaling, illustrated with the transcription factor MTF‐1, is similarly ambiguous. Once formed, the Zn‐proteome is preserved under Zn
2+
‐deficient conditions, but is susceptible to widespread metal exchange with Cd
2+
and reaction with other xenobiotics. Zn‐proteomic research extensively utilizes fluorescent sensors for Zn
2+
. Two of these, TSQ and Zinquin, form adducts with significant fractions of the Zn‐proteome and thereby reveal their status and reactivity under a variety of physiological and pathological conditions. The next step in the evolution of zinc proteomics will be to deconvolute collective Zn‐proteomic behavior into the reactions of individual Zn‐proteins. Methods are discussed that support this advance.